COVID-19: UK AstraZeneca to provide technology to Brazil:
COVID-19:
Sao Paulo
July 03, 2020
Brazilian Ministry of Health:
On June 27, we announced the vaccine for the new corona and the domestic production of 100 million doses.
We will procure 100 million doses of the vaccine composition (the drug substance) from Oxford University in the UK and AstraZeneca in the UK, which is developing a vaccine.
Announced the agreement to “license technology for vaccine production in Brazil”.
COVID-19 vaccine:
The COVID-19 vaccine is in the third stage of clinical trials to finally confirm its efficacy and safety.
Federal University of Sao Paulo (UNIFESP):
From June 19, the Union University of Sao Paulo (UNIFESP) has started inoculation to a total of 3,000 applicants for clinical trials in the cities of Sao Paulo and Rio de Janeiro.
Oswald Cruz Foundation (FIOCRUZ)
If the vaccination effect of the AstraZeneca vaccine is approved,
The Oswald Cruz Foundation (FIOCRUZ) procured the drug substance,
We will carry out research on the further efficacy and safety of vaccines and vaccine production.
China Sinovac Biotech:
On the 11th of June, the state government of São Paulo announced that the Butantan Institute and China Sinovac Biotech will cooperate to produce vaccines (see article on June 15, 2020).
-JETRO
https://www.jetro.go.jp/biznews/2020/07/c6ff61e81c535e02.html
AstraZeneca reaches supply deal with Brazilian government to produce millions of doses of COVID-19 shot
AstraZeneca and the government of Brazil
have inked a deal valued at $127 million to produce doses of the University of Oxford’s adenovirus-based COVID-19 vaccine candidate, AZD1222, as the country combats a rising count of new infections.
Brazil—which trails only the U.S. in terms of total reported COVID-19 cases and deaths—
will make available around 30 million finished doses of the vaccine, with roughly half that amount available by December, AstraZeneca said.
Brazil has also committed to produce an additional 70 million doses, with AstraZeneca supplying the unfinished vaccine at no cost.
FiercePharma
China aims to ‘lead the world’ in coronavirus vaccine race – Los Angeles Times